You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Obtenez les dernières mises à jour ou faites une autoévaluation.

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Lignes directrices et conseils

Cancer Care Ontario Bladder Cancer Guideline: An Endorsement of the 2017 American Urological Association Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA, ASCO, ASTRO, SUO Guide

ID: GL-END 3-21 Jan 2018
Type of Content: Guidelines & Advice, Clinical
Document Status: Current
Authors:
A. Finelli, T. Flood, G. Kulkarni, S. Hotte, M. O’Malley, The Genitourinary Cancer Advisory Committee

Guideline Objective

The objectives of this guideline are to provide clinical practice recommendations for the treatment of non-metastatic muscle-invasive bladder cancer (MIBC). Our recommendations are based on the 2017 American Urological Association (AUA) “Treatment of Non-Metastatic Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline”.

Patient Population

Patients with non-metastatic MIBC.

Intended Guideline Users

Primary care providers, urologists, radiation and medical oncologists, and other healthcare providers involved in the management of non-metastatic MIBC.

pdf download Full Report (PDF) (439.66 KB)